vanillic acid has been researched along with Disease Models, Animal in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 17 (73.91) | 24.3611 |
| 2020's | 5 (21.74) | 2.80 |
| Authors | Studies |
|---|---|
| Alasmari, WA; Alghamdi, MA; El-Hefnawy, MA; Hussein, AM; Nashar, EME; Obydah, W; Saad, S; Yehia, A | 1 |
| Amini-Khoei, H; Anjomshoa, M; Bijad, E; Farzan, M; Shabani, S; Shahrani, M | 1 |
| Ahmadi, N; Karimi, SA; Komaki, A; Mirazi, N; Safari, S | 1 |
| Alamgeer, -; Alharbi, KS; Alotaibi, NH; Batool, A; Bukhari, SNA; Irfan, HM; Locatelli, M; Saleem, H; Saleem, M; Younis, W | 1 |
| Khurana, N; Muthuraman, A; Sharma, N; Utreja, P | 1 |
| Badavi, M; Farbood, Y; Fathi Moghaddam, H; Khorsandi, L; Khoshnam, SE; Sarkaki, A | 1 |
| Farbood, Y; Khoshnam, SE; Rashno, M; Sarkaki, A | 1 |
| Bai, F; Fang, L; Feng, X; Hu, H; Sun, D; Yang, Y | 1 |
| Hu, Z; Li, ZY; Lyu, L; Mi, Y; Shi, YJ; Wang, CL; Zhang, YH | 1 |
| Jamali, KS; Kamal, A; Khan, F; Saify, ZS; Siddiqui, S | 1 |
| Balci Yuce, H; Gevrek, F; Karatas, O; Keskin, A; Ocak Karatas, SF; Taskan, MM; Toker, H; Ucan Yarkac, F | 1 |
| Alencar, MS; da Nóbrega, FR; de Oliveira, AP; de Souza, LKM; de Souza, MHLP; Iles, B; Medeiros, JVR; Nicolau, LAD; Nogueira, KM; Pacheco, G; Silva, RO; Sousa, DP | 1 |
| Kumar, S; Prahalathan, P; Raja, B | 1 |
| Chu, S; Fan, W; Fang, W; He, G; He, W; Huang, J; Kodithuwakku, ND; Li, Y; Wu, Q; Zhou, Y | 1 |
| Baracat, MM; Calixto-Campos, C; Carvalho, TT; Casagrande, R; Fattori, V; Georgetti, SR; Hohmann, MS; Manchope, MF; Pinho-Ribeiro, FA; Verri, WA; Zarpelon, AC | 1 |
| Kumar, S; Manivannan, J; Mishra, SK; Prahalathan, P; Raja, B; Saravanakumar, M; Silambarasan, T | 1 |
| Dinesh Kumar, B; Diwan, PV; Motiram Kakalij, R; Patil, MA; Tejaswini, G | 1 |
| Kim, M; Lim, SJ; Nam, EJ; Nho, CW; Randy, A | 1 |
| Gupta, S; Sane, SA; Shakya, N | 1 |
| Dhanasekar, K; Prince, PS; Rajakumar, S | 1 |
| Bajpai, P; Gupta, S; Sane, SA; Shakya, N; Vishwakarma, P | 1 |
| Raja, B; Saravanakumar, M | 1 |
| Gobianand, K; Karthikeyan, S; Priya, S; Vijayalakshmi, P; Vivekanandan, P | 1 |
23 other study(ies) available for vanillic acid and Disease Models, Animal
| Article | Year |
|---|---|
Effect of vanillic acid on pentylenetetrazole-kindled rats: Nrf2/HO-1, IGF-1 signaling pathways cross talk.
Topics: Animals; Anticonvulsants; Antioxidants; Convulsants; Disease Models, Animal; Epilepsy; Heme Oxygenase (Decyclizing); Insulin-Like Growth Factor I; Male; NF-E2-Related Factor 2; Pentylenetetrazole; Rats; Signal Transduction; Vanillic Acid | 2022 |
Protective effects of vanillic acid on autistic-like behaviors in a rat model of maternal separation stress: Behavioral, electrophysiological, molecular and histopathological alterations.
Topics: Animals; Antioxidants; Autism Spectrum Disorder; Autistic Disorder; Disease Models, Animal; Maternal Deprivation; Nitrites; Rats; Vanillic Acid | 2023 |
Effects of vanillic acid on Aβ
Topics: Amyloid beta-Peptides; Animals; Avoidance Learning; Disease Models, Animal; Hippocampus; Learning; Male; Malondialdehyde; Memory; Memory Disorders; Neurons; Oxidative Stress; Peptide Fragments; Rats; Vanillic Acid | 2021 |
Study on vascular mechanisms underlying the hypotensive effect of Sorghum halepense (L.) Pers.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Flavanones; Fructose; Hypertension; Male; Plant Extracts; Rats, Sprague-Dawley; Sorghum; Vanillic Acid; Vasodilation; Vasodilator Agents | 2020 |
Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model.
Topics: Animals; Antioxidants; Antiparkinson Agents; Behavior, Animal; Body Weight; Carbidopa; Catalase; Catalepsy; Disease Models, Animal; Dopamine; Drug Combinations; Female; Glutathione; Levodopa; Locomotion; Male; Mesencephalon; Muscular Diseases; Oxidative Stress; Parkinson Disease; Postural Balance; Rats, Sprague-Dawley; Rotenone; Superoxides; Thiobarbituric Acid Reactive Substances; Vanillic Acid | 2021 |
Vanillic acid attenuates cerebral hyperemia, blood-brain barrier disruption and anxiety-like behaviors in rats following transient bilateral common carotid occlusion and reperfusion.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Carotid Artery Diseases; Cerebrovascular Disorders; Disease Models, Animal; Hippocampus; Hyperemia; Male; Rats, Wistar; Reperfusion Injury; Vanillic Acid | 2018 |
Memory deficits and hippocampal inflammation in cerebral hypoperfusion and reperfusion in male rats: Neuroprotective role of vanillic acid.
Topics: Animals; Cerebrovascular Disorders; Disease Models, Animal; Hippocampus; Inflammation; Male; Memory Disorders; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Reperfusion; Vanillic Acid | 2018 |
Vanillic acid mitigates the ovalbumin (OVA)-induced asthma in rat model through prevention of airway inflammation.
Topics: Animals; Antioxidants; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Immunoglobulin E; Inflammation; Lung; Male; Malondialdehyde; Organ Size; Ovalbumin; Rats; Rats, Sprague-Dawley; Vanillic Acid | 2019 |
Serum Metabolic Profiling in a Mouse Model of Adriamycin-Induced Focal Segmental Glomerulosclerosis.
Topics: Animals; Body Weight; Computational Biology; Disease Models, Animal; Doxorubicin; Fatty Acids, Monounsaturated; Glomerulosclerosis, Focal Segmental; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred BALB C; Pyridoxine; Valine; Vanillic Acid | 2018 |
Gallic and vanillic acid suppress inflammation and promote myelination in an in vitro mouse model of neurodegeneration.
Topics: Action Potentials; Animals; Demyelinating Diseases; Disease Models, Animal; Extracellular Matrix Proteins; Gallic Acid; Glial Fibrillary Acidic Protein; Inflammation; Lysophosphatidylcholines; Mice, Inbred BALB C; Myelin Sheath; Nerve Degeneration; Neuronal Outgrowth; Vanillic Acid | 2019 |
The effect of vanillic acid on ligature-induced periodontal disease in Wistar rats.
Topics: Alveolar Bone Loss; Animals; Disease Models, Animal; Osteoclasts; Periodontitis; Rats; Rats, Wistar; Vanillic Acid | 2019 |
Efficacy of a phenol derivative, isopropyl vanillate, as an anti-inflammatory agent: A new small molecule inhibitor of COX and neutrophil migration.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Carrageenan; Cyclooxygenase Inhibitors; Disease Models, Animal; Female; Inflammation; Injections, Intraperitoneal; Male; Mice; Models, Molecular; Phenols; Small Molecule Libraries; Vanillic Acid | 2019 |
Vanillic acid: a potential inhibitor of cardiac and aortic wall remodeling in l-NAME induced hypertension through upregulation of endothelial nitric oxide synthase.
Topics: Animals; Aorta; Blood Pressure; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Hypertension; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Rats, Wistar; Vanillic Acid; Ventricular Function, Left | 2014 |
The neuroprotective effect of a novel agent N2 on rat cerebral ischemia associated with the activation of PI3K/Akt signaling pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain; Brain Ischemia; Cell Survival; Cells, Cultured; Disease Models, Animal; Imidazoles; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; Stroke; Vanillic Acid | 2015 |
Vanillic Acid Inhibits Inflammatory Pain by Inhibiting Neutrophil Recruitment, Oxidative Stress, Cytokine Production, and NFκB Activation in Mice.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Benzaldehydes; Benzoquinones; Carrageenan; Cytokines; Disease Models, Animal; Edema; Freund's Adjuvant; Hyperalgesia; Inflammation; Male; Mice; Molecular Structure; Neutrophil Infiltration; NF-kappa B; Oxidative Stress; Pain; Signal Transduction; Vanillic Acid | 2015 |
Oral administration of veratric acid, a constituent of vegetables and fruits, prevents cardiovascular remodelling in hypertensive rats: a functional evaluation.
Topics: Administration, Oral; Animals; Antioxidants; Aorta; Ascorbic Acid; Cardiovascular Diseases; Cardiovascular System; Catalase; Disease Models, Animal; Dose-Response Relationship, Drug; Fruit; Glutathione; Glutathione Peroxidase; Hypertension; Lipid Peroxidation; Lipid Peroxides; Male; NG-Nitroarginine Methyl Ester; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vanillic Acid; Vascular Remodeling; Vegetables; Vitamin E | 2015 |
Vanillic Acid Ameliorates Cationic Bovine Serum Albumin Induced Immune Complex Glomerulonephritis in BALB/c Mice.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerulonephritis; Immune Complex Diseases; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Methylprednisolone; Mice; Mice, Inbred BALB C; Serum Albumin, Bovine; Treatment Outcome; Vanillic Acid | 2016 |
Effects of Hovenia dulcis Thunb. extract and methyl vanillate on atopic dermatitis-like skin lesions and TNF-α/IFN-γ-induced chemokines production in HaCaT cells.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Chemokine CCL17; Chemokine CCL22; Chemokines; Dermatitis, Atopic; Dinitrochlorobenzene; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Immunoglobulin E; Immunoglobulin G; Interferon-gamma; Keratinocytes; Male; Mice; Mitogen-Activated Protein Kinases; Phytotherapy; Plant Extracts; Plants, Medicinal; Rhamnaceae; Signal Transduction; Skin; Th1 Cells; Th1-Th2 Balance; Th2 Cells; Transcription Factors; Tumor Necrosis Factor-alpha; Vanillic Acid | 2016 |
Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cell Proliferation; Cinnamates; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glycosides; Leishmania donovani; Leishmaniasis, Visceral; Lymphocytes; Male; Mesocricetus; Paromomycin; Phagocytosis; Phosphorylcholine; Random Allocation; Reactive Nitrogen Species; Reactive Oxygen Species; Vanillic Acid | 2011 |
Preventive effects of vanillic acid on lipids, bax, bcl-2 and myocardial infarct size on isoproterenol-induced myocardial infarcted rats: a biochemical and in vitro study.
Topics: Animals; bcl-2-Associated X Protein; Biphenyl Compounds; Creatine Kinase, MB Form; Disease Models, Animal; Free Radical Scavengers; Gene Expression Regulation; Isoproterenol; Lipid Metabolism; Lipids; Male; Myocardial Infarction; Myocardium; Picrates; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Vanillic Acid | 2011 |
Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv.
Topics: Animals; Antiprotozoal Agents; Cinnamates; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Female; Glycosides; Hydrogen Peroxide; Immunologic Factors; Ketoconazole; Leishmania donovani; Leishmaniasis, Visceral; Male; Phagocytosis; Phosphorylcholine; Reactive Nitrogen Species; Reactive Oxygen Species; Rodent Diseases; Treatment Outcome; Vanillic Acid | 2011 |
Effect of veratric acid on the cardiovascular risk of L-NAME-induced hypertensive rats.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Disease Models, Animal; Heart Rate; Hydroxymethylglutaryl CoA Reductases; Hyperlipidemias; Hypertension; Kidney; Lipid Metabolism; Lipids; Lipoproteins; Liver; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Risk Factors; Vanillic Acid | 2012 |
Protective effect of picroliv against hydrazine-induced hyperlipidemia and hepatic steatosis in rats.
Topics: Adipose Tissue; Animals; Cholesterol; Cinnamates; Disease Models, Animal; Fatty Acids, Nonesterified; Fatty Liver; Glycosides; Hydrazines; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Phospholipids; Rats; Rats, Wistar; Triglycerides; Vanillic Acid | 2007 |